The US FDA has granted a De Novo Classification for the Biolinq Shine, a novel real-time glucose sensor for people with type 2 diabetes (T2D) not on insulin. The new classification allows the company ...
Abbott Laboratories' said on Monday it had received clearance to market the smallest version of its fastest-growing low-cost diabetes monitoring product in the European Union.
HealthDay News — Continuous glucose monitors (CGMs) do not accurately reflect blood sugar control in people without diabetes, according to a study published online Oct. 1 in Diabetes Technology & ...
Continuous glucose monitoring can be successfully initiated during hospitalization with training for hospital staff, robust ...
The Cut on MSN
What Am I Doing Tracking My Blood Sugar?
Now, wellness obsessives are tracking their blood sugar around the clock, too. While continuous glucose monitors (CGMs) were initially intended to help people with diabetes manage their blood sugar, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback